Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology

Cellular Oncology

Volumn 30, Issue 1, 2008, Pages 27-38

  Jansen, Corine ^a   Hebeda, Konnie M ^a   Linkels, Marianne ^a   Grefte, Johanna M M ^a   Raemaekers, John M M ^a   Van Krieken, Johan H J M ^a   Groenen, Patricia J T A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Classification; Non Hodgkin's lymphoma; Protein profiling; Proteomics; SELDI TOF MS

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; CYTOLYSIS; FOLLICULAR LYMPHOMA; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TUMOR BIOPSY;

HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, NON-HODGKIN; NEOPLASM PROTEINS; PROTEIN ARRAY ANALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 38549138903     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. E.S. Jaffee, N.L. Harris, H. Skin and J.W. Vardiman (eds), World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues, IARC Press, Lyon, 2001.
2. M.S. Lim and K.S. Elenitoba-Johnson, Mass spectrometry-based proteomic studies of human anaplastic large cell lymphoma, Mol. Cell. Proteomics 5(10) (2006), 1787-1798.
3. K.S. Elenitoba-Johnson, D.K. Crockett, J.A. Schumacher, S.D. Jenson, C.M. Coffin, A.L. Rockwood et al., Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins, Proc. Natl. Acad. Sci. USA 103(19) (2006), 7402-7407.
4. C.P. Vaughn, D.K. Crockett, Z. Lin, M.S. Lim, K.S. Elenitoba-Johnson, Identification of proteins released by follicular lymphoma-derived cells using a mass spectrometry-based approach, Proteomics 6(10) (2006), 3223-3230.
5. M.P. Ebert, J. Meuer, J.C. Wiemer, H.U. Schulz, M.A. Reymond, U. Traugott et al., Identification of gastric cancer patients by serum protein profiling, J. Proteome Res. 3(6) (2004), 1261-1266.
6. E.T. Fung, T.T. Yip, L. Lomas, Z. Wang, C. Yip, X.Y. Meng et al., Classification of cancer types by measuring variants of host response proteins using SELDI serum assays, Int. J. Cancer 115(5) (2005), 783-789.
7. J. Koopmann, Z. Zhang, N. White, J. Rosenzweig, N. Fedarko, S. Jagannath et al., Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry, Clin. Cancer Res. 10(3) (2004), 860-868.
8. J. Li, Z. Zhang, J. Rosenzweig, Y.Y. Wang and D.W. Chan, Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer, Clin. Chem. 48(8) (2002), 1296-1304.
9. V. Paradis, F. Degos, D. Dargere, N. Pham, J. Belghiti, C. Degott et al., Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases, Hepatology 41(1) (2005), 40-47.
10. S.Y. Yang, X.Y. Xiao, W.G. Zhang, L.J. Zhang, W. Zhang, B. Zhou et al., Application of serum SELDI proteomic patterns in diagnosis of lung cancer, BMC Cancer 5 (2005), 83-90.
11. Y. Yu, S. Chen, L.S. Wang, W.L. Chen, W.J. Guo, H. Yan et al., Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification, Oncology 68(1) (2005), 79-86.
12. T. Yoshizaki, T. Enomoto, R. Nakashima, Y. Ueda, H. Kanao, K. Yoshino et al., Altered protein expression in endometrial carcinogenesis, Cancer Lett. 226(2) (2005), 101-106.
13. T.A. Zhukov, R.A. Johanson, A.B. Cantor, R.A. Clark, M.S. Tockman, Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry, Lung Cancer 40(3) (2003), 267-279.
14. Y.F. Wong, T.H. Cheung, K.W. Lo, V.W. Wang, C.S. Chan, T.B. Ng et al., Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix, Cancer Lett. 211(2) (2004), 227-234.
15. G. Kwapiszewska, M. Meyer, R. Bogumil, R.M. Bohle, W. Seeger, N. Weissmann et al., Identification of proteins in laser-microdissected small cell numbers by SELDI-TOF and Tandem MS, BMC Biotechnol. 4 (2004), 30-40.
16. I.N. Lee, C.H. Chen, J.C. Sheu, H.S. Lee, G.T. Huang, D.S. Chen et al., Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach, Proteomics 6(9) (2006), 2865-2873.
17. G. Malik, M.D. Ward, S.K. Gupta, M.W. Trosset, W.E. Grizzle, B.L. Adam et al., Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer, Clin. Cancer Res. 11(3) (2005), 1073-1085.
18. C. Melle, G. Ernst, B. Schimmel, A. Bleul, H. Mothes, R. Kaufmann et al., Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma, Int. J. Oncol. 28(1) (2006), 195-200.
19. G. Fan, M. Molstad, R.M. Braziel, M. Standley, J. Huang, W. Rodgers et al., Proteomic profiling of mature CD10+ B-cell lymphomas, Am. J. Clin. Pathol. 124(6) (2005), 920-929.
20. Z. Lin, S.D. Jenson, M.S. Lim, K.S. Elenitoba-Johnson, Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma, Mod. Pathol. 17(6) (2004), 670-678.
21. Federation of medical Scientific Societies. Code for proper secondary use of human tissue in the Netherlands, http://www.federa.org/?s=1&m=78&p= &v=4, 2002. Ref Type: Internet Communication.
22. M. Aivado, D. Spentzos, G. Alterovitz, H.H. Otu, F. Grall, A.A. Giagounidis et al., Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling, Clin. Chem. Lab. Med. 43(2) (2005), 133-140.
23. J. Albrethsen, R. Bogebo, J. Olsen, H. Raskov and S. Gammeltoft, Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum, Clin. Chem. Lab. Med. 44(10) (2006), 1243-1252.
24. C. Melle, G. Ernst, B. Schimmel, A. Bleul, S. Koscielny, A. Wiesner et al., Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip(R) technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry, Mol. Cell. Proteomics 2(7) (2003), 443-452.
25. L. Kopfstein and G. Christofori, Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment, Cell. Mol. Life Sci. 63(4) (2006), 449-468.
26. P. Schedin and A. Elias, Multistep tumorigenesis and the microenvironment, Breast Cancer Res. 6(2) (2004), 93-101.
27. F. Von Eggeling, H. Davies, L. Lomas, W. Fiedler, K. Junker, U. Claussen et al., Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research, Biotechniques 29(5) (2000), 1066-1070.
28. C.P. Paweletz, L.A. Liotta and E.F. Petricoin III, New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics, Urology 57(4, Suppl. 1) (2001), 160-163.
29. C. Rosty, L. Christa, S. Kuzdzal, W.M. Baldwin, M.L. Zahurak, F. Carnot et al., Identification of hepatocarcinoma-intestinepancreas/pancreatitis- associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology, Cancer Res. 62(6) (2002), 1868-1875.